Utopia SIS and CrowdFundMe have teamed up to raise €2.5 million for CaSRevolution, an innovative startup developing a new Alzheimer's treatment.

Target Information

Utopia SIS, a Simple Investment Company operating in the Life Sciences sector, has partnered with CrowdFundMe SpA, an equity crowdfunding platform listed on the Italian Stock Exchange, to support the capital raising efforts of CaSRevolution. This innovative startup is developing a treatment for Alzheimer's disease using a groundbreaking approach aimed at halting or at least slowing down neurodegeneration. CrowdFundMe has launched an equity crowdfunding campaign for CaSRevolution, while Utopia SIS has already invested €800,000 as the lead investor, having previously invested €700,000 in an earlier funding round.

CaSRevolution aims to raise a total of €2.5 million. Antonio Falcone, Executive Vice President of Utopia SIS, emphasized the success of this collaboration, stating that it demonstrates how two venture market players can combine their expertise to support a startup engaged in crucial research for combating Alzheimer's disease. This initiative marks a significant step in aligning investment strategies among venture capital players, as highlighted by Tommaso Baldissera Pacchetti, CEO of CrowdFundMe.

Industry Overview in Italy

The biotechnology and life sciences industry in Italy has seen significant growth over the past decade, driven by advancing research capabilities and increased public and private investments. Italian biotech compa